Continuous IV monitoring system developer ivWatch announced that it received FDA clearance for its new SmartTouch disposable sensor.
SmartTouch is indicated for the early detection of peripheral IV infiltration and extravasation events. The latest FDA clearance expands ivWatch’s sensor portfolio to include the single-use sensor for all patient age groups. It is miniaturized and disposable and adds functionality options for IV site placement as well, according to a news release.
When paired with the ivWatch patient monitor, the sensor helps to alert clinicians of infiltration and extravasation events often hours before they are detectable by visual or tactile examination, the company said. The Newport News, Va.-based company also issued an update for the user interface of the patient monitor to enhance clinician and patient experience.
Clinical data for the SmartTouch sensor revealed that it issued notifications for 99% of early-stage infiltrations in less than 10mL of infused IV fluid. Less than one false notification was issued every six days, as well.